title: Comparative antithrombotic and hemorrhagic effects of dermatan sulfate, heparan sulfate, and heparin.
authors.affiliation: Department of Pathology, Loyola University Medical Center, Maywood, Illinois 60153.
authors.forename: D
authors.initials: D
authors.lastname: Hoppensteadt
authors.forename: A
authors.initials: A
authors.lastname: Racanelli
authors.forename: J M
authors.initials: JM
authors.lastname: Walenga
authors.forename: J
authors.initials: J
authors.lastname: Fareed
mesh_terms: D000818:Animals; D001780:Blood Coagulation Tests; D002807:Chondroitin; D003871:Dermatan Sulfate / Q000627:therapeutic use* / Q000633:toxicity; D005343:Fibrinolytic Agents / Q000627:therapeutic use* / Q000633:toxicity; D006025:Glycosaminoglycans / Q000627:therapeutic use*; D006470:Hemorrhage / Q000139:chemically induced*; D006493:Heparin / Q000627:therapeutic use* / Q000633:toxicity; D006497:Heparan Sulfate / Q000627:therapeutic use* / Q000633:toxicity; D008297:Male; D011817:Rabbits; D013927:Thrombosis / Q000517:prevention & control*
chemical_list: D002807:Chondroitin; D003871:Dermatan Sulfate; D005343:Fibrinolytic Agents; D006025:Glycosaminoglycans; D006493:Heparin; D006497:Heparan Sulfate